TIMOTHY J KELLY
Medical Practice at Cork Oak St, Sarasota, FL
License number
Florida 508895
Issued Date
Feb 15, 2005
Effective Date
Aug 23, 2007
Expiration Date
Dec 1, 2006
Category
Health Care
Type
Emergency Medical Technician
Address
Address
2261 Cork Oak St, Sarasota, FL 34232
Phone
(941) 377-6508
Organization information
See more information about TIMOTHY J KELLY at bizstanding.comTimothy J. Kelly, Inc
PO Box 910, Sarasota, FL 34230
Status:
Inactive
Registration:
Jan 22, 1996
State ID:
P96000008071
Business type:
Domestic for Profit Corporation
Director:
Timothy J. Kelly Director, inactive
Professional information
Method Of Reducing Infections And/Or Air Embolisms Associated With Vascular Access Procedures
US Patent:
8007833, Aug 30, 2011
Filed:
Sep 10, 2009
Appl. No.:
12/557102
Inventors:
John Hen - Bradenton FL, US
Roger Thomas - Pinehurst NC, US
Griscom Bettle - Sarasota FL, US
Timothy J. Kelly - Sarasota FL, US
Roger Thomas - Pinehurst NC, US
Griscom Bettle - Sarasota FL, US
Timothy J. Kelly - Sarasota FL, US
Assignee:
Biolife, L.L.C. - Sarasota FL
International Classification:
A01N 59/16, A61M 31/00, A61M 37/00, A61B 17/20
US Classification:
424646, 604506, 604 46
Abstract:
A method of reducing infections associated with vascular access procedures. A powder containment device (PCD) is preferably adhesively attached to a skin area, the PCD having a hole formed centrally therethrough adapted to completely surround the catheter wound site. The open cavity formed by the PCD being attached to the skin is filled with a hemostatic agent of a salt ferrate and an insoluble cation exchange material. The salt ferrate combines with blood to form a trivalent Fe ion promoting blood clotting and producing oxygen at the wound site for bacteria reduction. The cation exchange material also forms a protective cover over the wound site as the trivalent Fe ion is formed. Semi-occlusive pressure is applied against the hemostatic agent for a time sufficient to arrest blood flow from the wound site right after inserting or removing the catheter. The PCD and hemostatic agent are then covered with an adhesive dressing. The occurrence of air embolisms introduced around the catheter is also reduced after the hemostatic agent has interacted to arrest blood flow around the catheter.